卵巢癌中的新辅助疗法:新兴范式和治疗前沿
Yuxuan Shi1, Xiong Wei2, Bairong Xia3
1Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China. Hefei, Anhui, 230031, China.
Critical reviews in oncology/hematology
|December 11, 2025
概括
手术前的新辅助疗法是晚期卵巢癌的关键治疗方法. 最近的研究重点是优化化疗,向药物和免疫疗法,以获得更好的患者结果.
科学领域:
- 妇科瘤学 妇科瘤学
- 医学瘤学 医学瘤学
- 癌症治疗研究 癌症治疗研究
背景情况:
- 晚期的卵巢癌,高瘤负荷和身体状况不佳,带来了重大的治疗挑战.
- 间歇性瘤细胞减小之后的新辅助疗法是管理这些复杂病例的既定策略.
研究的目的:
- 综合审查最近在治疗晚期卵巢癌的新辅助疗法的进展.
- 为优化临床治疗策略提供有价值的参考资料.
主要方法:
- 对新辅助疗法方案的当前文献的综述.
- 优化常规化疗,向药物和免疫疗法的分析.
- 评估单剂和多剂组合策略.
主要成果:
- 在优化新辅助剂剂剂量方案方面取得了显著的研究势头.
- 针对性药物和免疫疗法的整合是一个日益增长的趋势.
- 为了提高疗效,正在探索组合策略.
结论:
- 最近的进展为改善晚期卵巢癌的新辅助疗法提供了有希望的途径.
- 优化的治疗方案和新药对于改善治疗结果至关重要.
- 这一综述是未来临床实践和研究的基础.
更多相关视频
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K


